CMR
CMR substances in EU cosmetics
CMR substances are classified as carcinogenic, mutagenic or reprotoxic. This page lists all EU cosmetic annex entries that carry a CMR designation.
Records
1028 total| List | Entry | Substance | CAS | Max concentration | CMR classification |
|---|---|---|---|---|---|
| II | 1000 | 2-Methoxyethoxy)ethanol (Diethylene glycol monomethyl ether; DEGME)CAS 111-77-3 | 111-77-3 | — | Repr. 1B |
| II | 1001 | (+/-)-2-(2,4-Dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether (Tetraconazole - ISO)CAS 112281-77-3 | 112281-77-3 | — | Carc. 2 · Repr. 2 |
| II | 1002 | 4-[4-(1,3-Dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinoneCAS 114565-66-1 | 114565-66-1 | — | Carc. 2 |
| II | 1003 | 5,6,12,13-Tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetroneCAS 115662-06-1 | 115662-06-1 | — | Repr. 2 |
| II | 1004 | tris(2-Chloroethyl) phosphateCAS 115-96-8 | 115-96-8 | — | Repr. 1B · Carc. 2 |
| II | 1005 | 4'-Ethoxy-2-benzimidazoleanilideCAS 120187-29-3 | 120187-29-3 | — | Muta. 2 |
| II | 1006 | Nickel dihydroxide [1]; nickel hydroxide [2]CAS 12054-48-7 [1] / 11113-74-9 [2] | 12054-48-7 [1] / 11113-74-9 [2] | — | Carc. 1A · Repr. 1B · Muta. 2 |
| II | 1007 | N,N-DimethylanilineCAS 121-69-7 | 121-69-7 | — | Carc. 2 |
| II | 1008 | SimazineCAS 122-34-9 | 122-34-9 | — | Carc. 2 |
| II | 1009 | Bis(cyclopentadienyl)-bis(2,6-difluoro-3-(pyrrol-1-yl)-phenyl)titaniumCAS 125051-32-3 | 125051-32-3 | — | Repr. 2 |
| II | 1010 | N,N,N',N'-Tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethaneCAS 130728-76-6 | 130728-76-6 | — | Muta. 2 |
| II | 1011 | Divanadium pentaoxideCAS 1314-62-1 | 1314-62-1 | — | Muta. 2 · Repr. 2 |
| II | 1012 | Pentachlorophenol [1]; Sodium pentachlorophenolate [2]; Potassium pentachlorophenolate [3]CAS 87-86-5 [1]/131-52-2 [2]/7778-73-6 [3] | 87-86-5 [1]/131-52-2 [2]/7778-73-6 [3] | — | Carc. 2 |
| II | 1013 | PhosphamidonCAS 13171-21-6 | 13171-21-6 | — | Muta. 2 |
| II | 1014 | N-(Trichloromethylthio)phthalimide (Folpet - ISO)CAS 133-07-3 | 133-07-3 | — | Carc. 2 |
| II | 1015 | N-2-NaphthylanilineCAS 135-88-6 | 135-88-6 | — | Carc. 2 |
| II | 1017 | 1-Bromo-3,4,5-trifluorobenzeneCAS 138526-69-9 | 138526-69-9 | — | Carc. 2 |
| II | 1018 | PropazineCAS 139-40-2 | 139-40-2 | — | Carc. 2 |
| II | 1019 | 3-(4-Chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCACAS 140-41-0 | 140-41-0 | — | Carc. 2 |
| II | 102 | Colchicine, its salts and derivativesCAS 64-86-8 | 64-86-8 | — | Muta. 1B |
| II | 1020 | IsoxaflutoleCAS 141112-29-0 | 141112-29-0 | — | Repr. 2 |
| II | 1021 | Kresoxim-methylCAS 143390-89-0 | 143390-89-0 | — | Carc. 2 |
| II | 1022 | ChlordeconeCAS 143-50-0 | 143-50-0 | — | Carc. 2 |
| II | 1023 | 9-VinylcarbazoleCAS 1484-13-5 | 1484-13-5 | — | Muta. 2 |
| II | 1024 | 2-ethylhexanoic acid and its salts with the exception of those specified elsewhere in Annex VI to Regulation (EC) No 1272/2008.CAS 149-57-5/- | 149-57-5/- | — | Repr. 2 |
| II | 1025 | MonuronCAS 150-68-5 | 150-68-5 | — | Carc. 2 |
| II | 1026 | Morpholine-4-carbonyl chlorideCAS 15159-40-7 | 15159-40-7 | — | Carc. 2 |
| II | 1028 | Alachlor (ISO)CAS 15972-60-8 | 15972-60-8 | — | Carc. 2 |
| II | 1029 | UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamineCAS 166242-53-1 | 166242-53-1 | — | Carc. 2 |
| II | 1030 | 4-hydroxy-3,5-diiodobenzonitrile [1]; 4-Cyano-2,6-diiodophenyl octanoate [2]CAS 1689-83-4 [1] / 3861-47-0 [2] | 1689-83-4 [1] / 3861-47-0 [2] | — | Repr. 2 |
| II | 1031 | Bromoxynil (ISO) 3,5-Dibromo-4-hydroxybenzonitrile [1] and Bromoxynil heptanoate (ISO) [2]CAS 1689-84-5 [1] / 56634-95-8 [2] | 1689-84-5 [1] / 56634-95-8 [2] | — | Repr. 2 |
| II | 1032 | 2,6-Dibromo-4-cyanophenyl octanoateCAS 1689-99-2 | 1689-99-2 | — | Repr. 2 |
| II | 1034 | 5-Chloro-1,3-dihydro-2H-indol-2-oneCAS 17630-75-0 | 17630-75-0 | — | Repr. 2 |
| II | 1035 | Benomyl (ISO)CAS 17804-35-2 | 17804-35-2 | — | Muta. 1B · Repr. 1B |
| II | 1036 | ChlorothalonilCAS 1897-45-6 | 1897-45-6 | — | Carc. 2 |
| II | 1037 | N'-(4-Chloro-o-tolyl)-N,N-dimethylformamidine monohydrochlorideCAS 19750-95-9 | 19750-95-9 | — | Carc. 2 |
| II | 1038 | 4,4'-Methylenebis(2-ethylaniline)CAS 19900-65-3 | 19900-65-3 | — | Carc. 2 |
| II | 1039 | ValinamideCAS 20108-78-5 | 20108-78-5 | — | Repr. 2 |
| II | 1040 | [(p-Tolyloxy)methyl]oxiraneCAS 2186-24-5 | 2186-24-5 | — | Muta. 2 |
| II | 1041 | [(m-Tolyloxy)methyl]oxiraneCAS 2186-25-6 | 2186-25-6 | — | Muta. 2 |
| II | 1042 | 2,3-Epoxypropyl o-tolyl etherCAS 2210-79-9 | 2210-79-9 | — | Muta. 2 |
| II | 1043 | [(Tolyloxy)methyl]oxirane, cresyl glycidyl etherCAS 26447-14-3 | 26447-14-3 | — | Muta. 2 |
| II | 1044 | Di-allateCAS 2303-16-4 | 2303-16-4 | — | Carc. 2 |
| II | 1045 | Benzyl 2,4-dibromobutanoateCAS 23085-60-1 | 23085-60-1 | — | Repr. 2 |
| II | 1046 | TrifluoroiodomethaneCAS 2314-97-8 | 2314-97-8 | — | Muta. 2 |
| II | 1047 | Thiophanate-methylCAS 23564-05-8 | 23564-05-8 | — | Muta. 2 |
| II | 1048 | Dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane (Mirex)CAS 2385-85-5 | 2385-85-5 | — | Carc. 2 · Repr. 2 |
| II | 1049 | PropyzamideCAS 23950-58-5 | 23950-58-5 | — | Carc. 2 |
| II | 1050 | Butyl glycidyl etherCAS 2426-08-6 | 2426-08-6 | — | Carc. 2 · Muta. 2 |
| II | 1051 | 2,3,4-Trichlorobut-1-eneCAS 2431-50-7 | 2431-50-7 | — | Carc. 2 |
Source note for the CMR list
This filtered page shows 1028 annex records currently carrying a CMR marker in the local import of the EU cosmetic dataset.
Use this filtered view to identify potentially sensitive records quickly, but confirm current CMR status, derogations and annex placement against the official legal sources.
About CMR substances
CMR stands for Carcinogenic, Mutagenic or Reprotoxic. Under EU Regulation 1223/2009, CMR substances of category 1A and 1B are prohibited in cosmetics unless specifically allowed under Annex III conditions.
This list collects all annex entries that carry a CMR field value. Use the individual entry pages to review the full regulatory context, concentration limits and applicable warnings.